Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:VRP.
$4.36 +0.18 (4.19%)
As of 05/25/2022 15:53:42 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.